nodes	percent_of_prediction	percent_of_DWPC	metapath
Metipranolol—ADRB1—obesity	0.264	0.543	CbGaD
Metipranolol—ADRB2—obesity	0.222	0.457	CbGaD
Metipranolol—ADRB2—Phenylpropanolamine—obesity	0.183	0.504	CbGbCtD
Metipranolol—ADRB1—Phenylpropanolamine—obesity	0.18	0.496	CbGbCtD
Metipranolol—Angina pectoris—Phentermine—obesity	0.00136	0.0162	CcSEcCtD
Metipranolol—Acute coronary syndrome—Phentermine—obesity	0.00122	0.0146	CcSEcCtD
Metipranolol—Myocardial infarction—Phentermine—obesity	0.00122	0.0146	CcSEcCtD
Metipranolol—Palpitations—Methamphetamine—obesity	0.00119	0.0143	CcSEcCtD
Metipranolol—Palpitations—Benzphetamine—obesity	0.00115	0.0138	CcSEcCtD
Metipranolol—Vision blurred—Phendimetrazine—obesity	0.00112	0.0134	CcSEcCtD
Metipranolol—Palpitations—Phendimetrazine—obesity	0.00105	0.0125	CcSEcCtD
Metipranolol—Tension—Phenylpropanolamine—obesity	0.000995	0.0119	CcSEcCtD
Metipranolol—Nervousness—Phenylpropanolamine—obesity	0.000985	0.0118	CcSEcCtD
Metipranolol—Vision blurred—Phenylpropanolamine—obesity	0.000956	0.0114	CcSEcCtD
Metipranolol—Tension—Phentermine—obesity	0.000952	0.0114	CcSEcCtD
Metipranolol—Nervousness—Phentermine—obesity	0.000943	0.0113	CcSEcCtD
Metipranolol—Bradycardia—Cimetidine—obesity	0.000939	0.0112	CcSEcCtD
Metipranolol—Lacrimation increased—Bupropion—obesity	0.000929	0.0111	CcSEcCtD
Metipranolol—Anxiety—Phenylpropanolamine—obesity	0.00086	0.0103	CcSEcCtD
Metipranolol—Palpitations—Phentermine—obesity	0.000858	0.0103	CcSEcCtD
Metipranolol—Abnormal vision—Sibutramine—obesity	0.000856	0.0102	CcSEcCtD
Metipranolol—Hypertension—Phentermine—obesity	0.000838	0.01	CcSEcCtD
Metipranolol—Tension—Diethylpropion—obesity	0.000829	0.0099	CcSEcCtD
Metipranolol—Nervousness—Diethylpropion—obesity	0.00082	0.0098	CcSEcCtD
Metipranolol—Hypersensitivity—Methamphetamine—obesity	0.000812	0.00971	CcSEcCtD
Metipranolol—Photophobia—Bupropion—obesity	0.000804	0.00961	CcSEcCtD
Metipranolol—Vision blurred—Diethylpropion—obesity	0.000796	0.00951	CcSEcCtD
Metipranolol—Oedema—Phentermine—obesity	0.000792	0.00947	CcSEcCtD
Metipranolol—Hypersensitivity—Benzphetamine—obesity	0.000783	0.00936	CcSEcCtD
Metipranolol—Arthritis—Orlistat—obesity	0.000758	0.00906	CcSEcCtD
Metipranolol—Atrial fibrillation—Sibutramine—obesity	0.000752	0.00899	CcSEcCtD
Metipranolol—Palpitations—Diethylpropion—obesity	0.000746	0.00892	CcSEcCtD
Metipranolol—Dyspnoea—Phenylpropanolamine—obesity	0.000738	0.00882	CcSEcCtD
Metipranolol—Somnolence—Phenylpropanolamine—obesity	0.000736	0.00879	CcSEcCtD
Metipranolol—Arthritis—Sibutramine—obesity	0.000733	0.00877	CcSEcCtD
Metipranolol—Dizziness—Methamphetamine—obesity	0.000729	0.00871	CcSEcCtD
Metipranolol—Myalgia—Diethylpropion—obesity	0.000719	0.00859	CcSEcCtD
Metipranolol—Anxiety—Diethylpropion—obesity	0.000716	0.00856	CcSEcCtD
Metipranolol—Discomfort—Diethylpropion—obesity	0.00071	0.00849	CcSEcCtD
Metipranolol—Dizziness—Benzphetamine—obesity	0.000703	0.0084	CcSEcCtD
Metipranolol—Headache—Methamphetamine—obesity	0.000691	0.00826	CcSEcCtD
Metipranolol—Myalgia—Cimetidine—obesity	0.000684	0.00817	CcSEcCtD
Metipranolol—Anxiety—Cimetidine—obesity	0.000682	0.00815	CcSEcCtD
Metipranolol—Headache—Benzphetamine—obesity	0.000666	0.00796	CcSEcCtD
Metipranolol—Dizziness—Phendimetrazine—obesity	0.000641	0.00766	CcSEcCtD
Metipranolol—Arthritis—Bupropion—obesity	0.000639	0.00764	CcSEcCtD
Metipranolol—Nausea—Benzphetamine—obesity	0.000631	0.00755	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Diethylpropion—obesity	0.000628	0.0075	CcSEcCtD
Metipranolol—Dyspnoea—Diethylpropion—obesity	0.000614	0.00734	CcSEcCtD
Metipranolol—Somnolence—Diethylpropion—obesity	0.000613	0.00732	CcSEcCtD
Metipranolol—Hypersensitivity—Phenylpropanolamine—obesity	0.00061	0.00729	CcSEcCtD
Metipranolol—Headache—Phendimetrazine—obesity	0.000607	0.00726	CcSEcCtD
Metipranolol—Angina pectoris—Sibutramine—obesity	0.0006	0.00717	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Cimetidine—obesity	0.000597	0.00714	CcSEcCtD
Metipranolol—Bronchitis—Sibutramine—obesity	0.000592	0.00708	CcSEcCtD
Metipranolol—Lacrimation increased—Topiramate—obesity	0.000592	0.00707	CcSEcCtD
Metipranolol—Somnolence—Cimetidine—obesity	0.000583	0.00697	CcSEcCtD
Metipranolol—Nausea—Phendimetrazine—obesity	0.000576	0.00688	CcSEcCtD
Metipranolol—Asthenia—Phentermine—obesity	0.000568	0.00679	CcSEcCtD
Metipranolol—Dizziness—Phenylpropanolamine—obesity	0.000547	0.00654	CcSEcCtD
Metipranolol—Acute coronary syndrome—Sibutramine—obesity	0.000541	0.00647	CcSEcCtD
Metipranolol—Myocardial infarction—Sibutramine—obesity	0.000538	0.00644	CcSEcCtD
Metipranolol—Conjunctivitis—Sibutramine—obesity	0.000534	0.00638	CcSEcCtD
Metipranolol—Dizziness—Phentermine—obesity	0.000524	0.00626	CcSEcCtD
Metipranolol—Rash—Phenylpropanolamine—obesity	0.000522	0.00624	CcSEcCtD
Metipranolol—Dermatitis—Phenylpropanolamine—obesity	0.000521	0.00623	CcSEcCtD
Metipranolol—Epistaxis—Sibutramine—obesity	0.000518	0.00619	CcSEcCtD
Metipranolol—Bronchitis—Bupropion—obesity	0.000516	0.00617	CcSEcCtD
Metipranolol—Photophobia—Topiramate—obesity	0.000512	0.00612	CcSEcCtD
Metipranolol—Bradycardia—Sibutramine—obesity	0.000502	0.006	CcSEcCtD
Metipranolol—Rash—Phentermine—obesity	0.000499	0.00597	CcSEcCtD
Metipranolol—Dermatitis—Phentermine—obesity	0.000499	0.00596	CcSEcCtD
Metipranolol—Headache—Phentermine—obesity	0.000496	0.00593	CcSEcCtD
Metipranolol—Rhinitis—Sibutramine—obesity	0.000494	0.00591	CcSEcCtD
Metipranolol—Nausea—Phenylpropanolamine—obesity	0.000492	0.00588	CcSEcCtD
Metipranolol—Hypersensitivity—Cimetidine—obesity	0.000483	0.00577	CcSEcCtD
Metipranolol—Abnormal vision—Topiramate—obesity	0.000476	0.00568	CcSEcCtD
Metipranolol—Visual impairment—Sibutramine—obesity	0.000475	0.00568	CcSEcCtD
Metipranolol—Acute coronary syndrome—Bupropion—obesity	0.000472	0.00564	CcSEcCtD
Metipranolol—Nausea—Phentermine—obesity	0.00047	0.00562	CcSEcCtD
Metipranolol—Asthenia—Cimetidine—obesity	0.00047	0.00562	CcSEcCtD
Metipranolol—Myocardial infarction—Bupropion—obesity	0.000469	0.00561	CcSEcCtD
Metipranolol—Conjunctivitis—Bupropion—obesity	0.000465	0.00556	CcSEcCtD
Metipranolol—Dizziness—Diethylpropion—obesity	0.000456	0.00545	CcSEcCtD
Metipranolol—Epistaxis—Bupropion—obesity	0.000452	0.0054	CcSEcCtD
Metipranolol—Alprenolol—ADRB3—obesity	0.000445	0.0893	CrCbGaD
Metipranolol—Rash—Diethylpropion—obesity	0.000434	0.00519	CcSEcCtD
Metipranolol—Dermatitis—Diethylpropion—obesity	0.000434	0.00519	CcSEcCtD
Metipranolol—Dizziness—Cimetidine—obesity	0.000434	0.00518	CcSEcCtD
Metipranolol—Headache—Diethylpropion—obesity	0.000432	0.00516	CcSEcCtD
Metipranolol—Rhinitis—Bupropion—obesity	0.000431	0.00515	CcSEcCtD
Metipranolol—Tension—Sibutramine—obesity	0.000421	0.00503	CcSEcCtD
Metipranolol—Vision blurred—Orlistat—obesity	0.000418	0.005	CcSEcCtD
Metipranolol—Nervousness—Sibutramine—obesity	0.000417	0.00498	CcSEcCtD
Metipranolol—Visual impairment—Bupropion—obesity	0.000414	0.00495	CcSEcCtD
Metipranolol—Rash—Cimetidine—obesity	0.000413	0.00494	CcSEcCtD
Metipranolol—Dermatitis—Cimetidine—obesity	0.000413	0.00494	CcSEcCtD
Metipranolol—Headache—Cimetidine—obesity	0.000411	0.00491	CcSEcCtD
Metipranolol—Nausea—Diethylpropion—obesity	0.000409	0.00489	CcSEcCtD
Metipranolol—Vision blurred—Sibutramine—obesity	0.000405	0.00483	CcSEcCtD
Metipranolol—Palpitations—Orlistat—obesity	0.000392	0.00468	CcSEcCtD
Metipranolol—Nausea—Cimetidine—obesity	0.000389	0.00465	CcSEcCtD
Metipranolol—Cough—Orlistat—obesity	0.000387	0.00463	CcSEcCtD
Metipranolol—Practolol—ADRB1—obesity	0.000383	0.0769	CrCbGaD
Metipranolol—Pindolol—ADRB3—obesity	0.000382	0.0768	CrCbGaD
Metipranolol—Palpitations—Sibutramine—obesity	0.000379	0.00453	CcSEcCtD
Metipranolol—Myalgia—Orlistat—obesity	0.000378	0.00451	CcSEcCtD
Metipranolol—Anxiety—Orlistat—obesity	0.000376	0.0045	CcSEcCtD
Metipranolol—Cough—Sibutramine—obesity	0.000375	0.00448	CcSEcCtD
Metipranolol—Discomfort—Orlistat—obesity	0.000373	0.00446	CcSEcCtD
Metipranolol—Hypertension—Sibutramine—obesity	0.000371	0.00443	CcSEcCtD
Metipranolol—Tension—Bupropion—obesity	0.000367	0.00439	CcSEcCtD
Metipranolol—Myalgia—Sibutramine—obesity	0.000365	0.00437	CcSEcCtD
Metipranolol—Anxiety—Sibutramine—obesity	0.000364	0.00435	CcSEcCtD
Metipranolol—Nervousness—Bupropion—obesity	0.000363	0.00434	CcSEcCtD
Metipranolol—Oedema—Orlistat—obesity	0.000362	0.00433	CcSEcCtD
Metipranolol—Discomfort—Sibutramine—obesity	0.000361	0.00432	CcSEcCtD
Metipranolol—Vision blurred—Bupropion—obesity	0.000353	0.00421	CcSEcCtD
Metipranolol—Oedema—Sibutramine—obesity	0.00035	0.00419	CcSEcCtD
Metipranolol—Angina pectoris—Topiramate—obesity	0.000333	0.00398	CcSEcCtD
Metipranolol—Palpitations—Bupropion—obesity	0.000331	0.00395	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Orlistat—obesity	0.00033	0.00394	CcSEcCtD
Metipranolol—Bronchitis—Topiramate—obesity	0.000329	0.00393	CcSEcCtD
Metipranolol—Cough—Bupropion—obesity	0.000327	0.0039	CcSEcCtD
Metipranolol—Hypertension—Bupropion—obesity	0.000323	0.00386	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Sibutramine—obesity	0.000319	0.00381	CcSEcCtD
Metipranolol—Myalgia—Bupropion—obesity	0.000319	0.00381	CcSEcCtD
Metipranolol—Anxiety—Bupropion—obesity	0.000317	0.00379	CcSEcCtD
Metipranolol—Discomfort—Bupropion—obesity	0.000315	0.00376	CcSEcCtD
Metipranolol—Dyspnoea—Sibutramine—obesity	0.000312	0.00373	CcSEcCtD
Metipranolol—Somnolence—Sibutramine—obesity	0.000311	0.00372	CcSEcCtD
Metipranolol—Oedema—Bupropion—obesity	0.000305	0.00365	CcSEcCtD
Metipranolol—Conjunctivitis—Topiramate—obesity	0.000297	0.00354	CcSEcCtD
Metipranolol—Acebutolol—SLC22A1—obesity	0.000292	0.0586	CrCbGaD
Metipranolol—Epistaxis—Topiramate—obesity	0.000288	0.00344	CcSEcCtD
Metipranolol—Bradycardia—Topiramate—obesity	0.000279	0.00333	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Bupropion—obesity	0.000278	0.00333	CcSEcCtD
Metipranolol—Esmolol—ADRB1—obesity	0.000275	0.0552	CrCbGaD
Metipranolol—Rhinitis—Topiramate—obesity	0.000275	0.00328	CcSEcCtD
Metipranolol—Dyspnoea—Bupropion—obesity	0.000272	0.00325	CcSEcCtD
Metipranolol—Somnolence—Bupropion—obesity	0.000271	0.00324	CcSEcCtD
Metipranolol—Hypersensitivity—Orlistat—obesity	0.000267	0.00319	CcSEcCtD
Metipranolol—Visual impairment—Topiramate—obesity	0.000264	0.00315	CcSEcCtD
Metipranolol—Asthenia—Orlistat—obesity	0.00026	0.0031	CcSEcCtD
Metipranolol—Hypersensitivity—Sibutramine—obesity	0.000258	0.00308	CcSEcCtD
Metipranolol—Asthenia—Sibutramine—obesity	0.000251	0.003	CcSEcCtD
Metipranolol—Atenolol—ADRB1—obesity	0.00024	0.0482	CrCbGaD
Metipranolol—Dizziness—Orlistat—obesity	0.000239	0.00286	CcSEcCtD
Metipranolol—Tension—Topiramate—obesity	0.000234	0.0028	CcSEcCtD
Metipranolol—Dizziness—Sibutramine—obesity	0.000232	0.00277	CcSEcCtD
Metipranolol—Nervousness—Topiramate—obesity	0.000232	0.00277	CcSEcCtD
Metipranolol—Esmolol—ADRB2—obesity	0.000231	0.0464	CrCbGaD
Metipranolol—Rash—Orlistat—obesity	0.000228	0.00273	CcSEcCtD
Metipranolol—Dermatitis—Orlistat—obesity	0.000228	0.00273	CcSEcCtD
Metipranolol—Headache—Orlistat—obesity	0.000227	0.00271	CcSEcCtD
Metipranolol—Hypersensitivity—Bupropion—obesity	0.000225	0.00269	CcSEcCtD
Metipranolol—Vision blurred—Topiramate—obesity	0.000225	0.00269	CcSEcCtD
Metipranolol—Acebutolol—ADRB1—obesity	0.000221	0.0445	CrCbGaD
Metipranolol—Rash—Sibutramine—obesity	0.000221	0.00264	CcSEcCtD
Metipranolol—Dermatitis—Sibutramine—obesity	0.000221	0.00264	CcSEcCtD
Metipranolol—Oxprenolol—ADRB1—obesity	0.00022	0.0441	CrCbGaD
Metipranolol—Headache—Sibutramine—obesity	0.000219	0.00262	CcSEcCtD
Metipranolol—Asthenia—Bupropion—obesity	0.000219	0.00262	CcSEcCtD
Metipranolol—Nausea—Orlistat—obesity	0.000215	0.00257	CcSEcCtD
Metipranolol—Palpitations—Topiramate—obesity	0.000211	0.00252	CcSEcCtD
Metipranolol—Propranolol—ADRB3—obesity	0.000209	0.0419	CrCbGaD
Metipranolol—Nausea—Sibutramine—obesity	0.000208	0.00249	CcSEcCtD
Metipranolol—Cough—Topiramate—obesity	0.000208	0.00249	CcSEcCtD
Metipranolol—Hypertension—Topiramate—obesity	0.000206	0.00246	CcSEcCtD
Metipranolol—Myalgia—Topiramate—obesity	0.000203	0.00243	CcSEcCtD
Metipranolol—Anxiety—Topiramate—obesity	0.000202	0.00242	CcSEcCtD
Metipranolol—Dizziness—Bupropion—obesity	0.000202	0.00241	CcSEcCtD
Metipranolol—Atenolol—ADRB2—obesity	0.000202	0.0405	CrCbGaD
Metipranolol—Alprenolol—ADRB1—obesity	0.000201	0.0404	CrCbGaD
Metipranolol—Discomfort—Topiramate—obesity	0.000201	0.0024	CcSEcCtD
Metipranolol—Pindolol—HTR1B—obesity	0.000195	0.0393	CrCbGaD
Metipranolol—Oedema—Topiramate—obesity	0.000195	0.00233	CcSEcCtD
Metipranolol—Rash—Bupropion—obesity	0.000193	0.0023	CcSEcCtD
Metipranolol—Dermatitis—Bupropion—obesity	0.000192	0.0023	CcSEcCtD
Metipranolol—Headache—Bupropion—obesity	0.000191	0.00229	CcSEcCtD
Metipranolol—Metoprolol—ADRB1—obesity	0.000187	0.0375	CrCbGaD
Metipranolol—Acebutolol—ADRB2—obesity	0.000186	0.0374	CrCbGaD
Metipranolol—Oxprenolol—ADRB2—obesity	0.000185	0.0371	CrCbGaD
Metipranolol—Nausea—Bupropion—obesity	0.000181	0.00217	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Topiramate—obesity	0.000177	0.00212	CcSEcCtD
Metipranolol—Dyspnoea—Topiramate—obesity	0.000173	0.00207	CcSEcCtD
Metipranolol—Somnolence—Topiramate—obesity	0.000173	0.00207	CcSEcCtD
Metipranolol—Pindolol—ADRB1—obesity	0.000173	0.0347	CrCbGaD
Metipranolol—Alprenolol—ADRB2—obesity	0.000169	0.034	CrCbGaD
Metipranolol—Metoprolol—ADRB2—obesity	0.000157	0.0316	CrCbGaD
Metipranolol—Pindolol—ADRB2—obesity	0.000145	0.0292	CrCbGaD
Metipranolol—Hypersensitivity—Topiramate—obesity	0.000143	0.00171	CcSEcCtD
Metipranolol—Asthenia—Topiramate—obesity	0.00014	0.00167	CcSEcCtD
Metipranolol—Dizziness—Topiramate—obesity	0.000129	0.00154	CcSEcCtD
Metipranolol—Rash—Topiramate—obesity	0.000123	0.00147	CcSEcCtD
Metipranolol—Dermatitis—Topiramate—obesity	0.000123	0.00146	CcSEcCtD
Metipranolol—Headache—Topiramate—obesity	0.000122	0.00146	CcSEcCtD
Metipranolol—Nausea—Topiramate—obesity	0.000116	0.00138	CcSEcCtD
Metipranolol—Propranolol—HTR1B—obesity	0.000107	0.0214	CrCbGaD
Metipranolol—Propranolol—ADRB1—obesity	9.43e-05	0.0189	CrCbGaD
Metipranolol—Propranolol—ADRB2—obesity	7.93e-05	0.0159	CrCbGaD
Metipranolol—ADRB2—Signaling by GPCR—DRD4—obesity	2.36e-05	0.000384	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—CCL2—obesity	2.35e-05	0.000381	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—CNR1—obesity	2.31e-05	0.000374	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CNR1—obesity	2.26e-05	0.000366	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—DRD2—obesity	2.25e-05	0.000365	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—GCG—obesity	2.23e-05	0.000362	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—ADRB2—obesity	2.22e-05	0.00036	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ADRB3—obesity	2.21e-05	0.000358	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—DRD2—obesity	2.2e-05	0.000357	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—GCG—obesity	2.18e-05	0.000354	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ADRB3—obesity	2.16e-05	0.00035	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GAL—obesity	2.16e-05	0.00035	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—C5AR1—obesity	2.13e-05	0.000346	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—GNB3—obesity	2.12e-05	0.000343	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GAL—obesity	2.11e-05	0.000342	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—C5AR1—obesity	2.08e-05	0.000338	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—GNB3—obesity	2.07e-05	0.000336	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—GNAS—obesity	2.06e-05	0.000334	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—ADRB2—obesity	2.02e-05	0.000327	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—GNAS—obesity	2.01e-05	0.000327	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—CCL5—obesity	1.97e-05	0.00032	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PRKG1—obesity	1.95e-05	0.000316	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CCK—obesity	1.95e-05	0.000316	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—CCL5—obesity	1.93e-05	0.000313	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—GNB3—obesity	1.92e-05	0.000312	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CCK—obesity	1.91e-05	0.000309	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PRKG1—obesity	1.91e-05	0.000309	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—RBP4—obesity	1.9e-05	0.000308	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GLP1R—obesity	1.9e-05	0.000308	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—GNB3—obesity	1.88e-05	0.000305	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—GNAS—obesity	1.87e-05	0.000303	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CCKAR—obesity	1.87e-05	0.000303	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HRH3—obesity	1.87e-05	0.000303	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—RBP4—obesity	1.86e-05	0.000301	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GLP1R—obesity	1.86e-05	0.000301	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—GNAS—obesity	1.83e-05	0.000297	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CCKAR—obesity	1.83e-05	0.000297	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HRH3—obesity	1.83e-05	0.000297	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PRKAR2B—obesity	1.8e-05	0.000292	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—CCL5—obesity	1.79e-05	0.00029	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—PRKCD—obesity	1.77e-05	0.000288	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PRKAR2B—obesity	1.76e-05	0.000285	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CCL5—obesity	1.75e-05	0.000284	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NCF2—obesity	1.74e-05	0.000282	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—HTR2A—obesity	1.74e-05	0.000282	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—PRKCD—obesity	1.74e-05	0.000282	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—C3—obesity	1.73e-05	0.000281	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NCF2—obesity	1.7e-05	0.000276	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—HTR2A—obesity	1.7e-05	0.000276	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—C3—obesity	1.7e-05	0.000275	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NPY—obesity	1.69e-05	0.000275	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—APOC3—obesity	1.68e-05	0.000273	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—IAPP—obesity	1.68e-05	0.000273	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NPY—obesity	1.66e-05	0.000269	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—AGT—obesity	1.65e-05	0.000267	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—IAPP—obesity	1.65e-05	0.000267	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—APOC3—obesity	1.65e-05	0.000267	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR1B—obesity	1.63e-05	0.000265	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CRH—obesity	1.63e-05	0.000265	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—SDC1—obesity	1.61e-05	0.000262	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—AGT—obesity	1.61e-05	0.000261	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—PRKCD—obesity	1.61e-05	0.000261	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR1B—obesity	1.6e-05	0.000259	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CRH—obesity	1.6e-05	0.000259	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—AKR1C3—obesity	1.59e-05	0.000258	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—SDC1—obesity	1.58e-05	0.000256	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HTR2A—obesity	1.58e-05	0.000256	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PRKCD—obesity	1.58e-05	0.000256	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—C3—obesity	1.57e-05	0.000255	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—AKR1C3—obesity	1.55e-05	0.000252	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NPS—obesity	1.55e-05	0.000251	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HTR2A—obesity	1.54e-05	0.00025	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—C3—obesity	1.54e-05	0.00025	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—PRKCB—obesity	1.52e-05	0.000247	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—F2—obesity	1.52e-05	0.000247	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—DRD1—obesity	1.52e-05	0.000246	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR2C—obesity	1.52e-05	0.000246	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NPS—obesity	1.51e-05	0.000246	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—AGT—obesity	1.5e-05	0.000243	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—PRKCB—obesity	1.49e-05	0.000242	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—F2—obesity	1.49e-05	0.000242	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR2C—obesity	1.49e-05	0.000241	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—DRD1—obesity	1.49e-05	0.000241	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NTRK2—obesity	1.48e-05	0.00024	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—AGT—obesity	1.46e-05	0.000237	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—PIK3CG—obesity	1.46e-05	0.000236	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NTRK2—obesity	1.44e-05	0.000234	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GHRL—obesity	1.44e-05	0.000234	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PARP1—obesity	1.44e-05	0.000234	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ADRB1—obesity	1.44e-05	0.000233	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—DRD4—obesity	1.43e-05	0.000232	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—PIK3CG—obesity	1.43e-05	0.000231	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GHRL—obesity	1.41e-05	0.000228	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PARP1—obesity	1.41e-05	0.000228	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—DRD4—obesity	1.4e-05	0.000227	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—POMC—obesity	1.39e-05	0.000225	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—PRKCB—obesity	1.38e-05	0.000224	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—F2—obesity	1.38e-05	0.000224	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CNR1—obesity	1.36e-05	0.000221	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—POMC—obesity	1.36e-05	0.00022	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PRKCB—obesity	1.35e-05	0.000219	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—F2—obesity	1.35e-05	0.000219	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—TCF7L2—obesity	1.34e-05	0.000217	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CNR1—obesity	1.33e-05	0.000216	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—AKT2—obesity	1.33e-05	0.000216	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—DRD2—obesity	1.33e-05	0.000216	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—PIK3CG—obesity	1.32e-05	0.000215	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GCG—obesity	1.32e-05	0.000214	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PTPN1—obesity	1.32e-05	0.000214	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—TCF7L2—obesity	1.31e-05	0.000213	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—AKT2—obesity	1.3e-05	0.000212	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—DRD2—obesity	1.3e-05	0.000211	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PIK3CG—obesity	1.29e-05	0.00021	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GCG—obesity	1.29e-05	0.000209	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PTPN1—obesity	1.29e-05	0.000209	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—PIK3CD—obesity	1.28e-05	0.000208	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—POMC—obesity	1.26e-05	0.000204	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PRL—obesity	1.26e-05	0.000204	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—PIK3CD—obesity	1.25e-05	0.000203	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—STK11—obesity	1.24e-05	0.000201	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—CCL2—obesity	1.23e-05	0.0002	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—POMC—obesity	1.23e-05	0.0002	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PRL—obesity	1.23e-05	0.000199	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PLG—obesity	1.22e-05	0.000199	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—RHOA—obesity	1.22e-05	0.000198	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—STK11—obesity	1.21e-05	0.000196	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—AKT2—obesity	1.21e-05	0.000196	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—PIK3R1—obesity	1.21e-05	0.000196	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CCL2—obesity	1.21e-05	0.000196	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PLG—obesity	1.2e-05	0.000194	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—RHOA—obesity	1.2e-05	0.000194	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—FOXO3—obesity	1.19e-05	0.000194	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ADRB2—obesity	1.19e-05	0.000193	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—AKT2—obesity	1.18e-05	0.000192	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—PIK3R1—obesity	1.18e-05	0.000192	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—SOCS1—obesity	1.17e-05	0.00019	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—FOXO3—obesity	1.17e-05	0.00019	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—PIK3CD—obesity	1.16e-05	0.000189	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—SOCS3—obesity	1.16e-05	0.000188	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—SOCS1—obesity	1.15e-05	0.000186	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PIK3CD—obesity	1.14e-05	0.000185	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GNB3—obesity	1.13e-05	0.000184	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—SOCS3—obesity	1.13e-05	0.000184	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—TYK2—obesity	1.12e-05	0.000182	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—PIK3CB—obesity	1.12e-05	0.000181	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—IGF2—obesity	1.11e-05	0.000181	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GNB3—obesity	1.11e-05	0.00018	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—RHOA—obesity	1.11e-05	0.00018	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GNAS—obesity	1.1e-05	0.000179	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—PIK3R1—obesity	1.1e-05	0.000178	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—TYK2—obesity	1.09e-05	0.000178	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—PIK3CB—obesity	1.09e-05	0.000177	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—IGF2—obesity	1.09e-05	0.000177	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—RHOA—obesity	1.09e-05	0.000176	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—APOB—obesity	1.08e-05	0.000176	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GNAS—obesity	1.08e-05	0.000175	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PIK3R1—obesity	1.07e-05	0.000174	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—APOB—obesity	1.06e-05	0.000172	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CCL5—obesity	1.06e-05	0.000171	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CCL5—obesity	1.03e-05	0.000168	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—LPL—obesity	1.03e-05	0.000168	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—FOXO1—obesity	1.03e-05	0.000166	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—RPS6KB1—obesity	1.02e-05	0.000166	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—PIK3CB—obesity	1.01e-05	0.000164	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—LPL—obesity	1.01e-05	0.000164	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—FOXO1—obesity	1e-05	0.000163	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—RPS6KB1—obesity	1e-05	0.000163	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PIK3CB—obesity	9.92e-06	0.000161	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PRKCD—obesity	9.52e-06	0.000154	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR2A—obesity	9.31e-06	0.000151	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PRKCD—obesity	9.31e-06	0.000151	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—C3—obesity	9.3e-06	0.000151	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR2A—obesity	9.11e-06	0.000148	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—C3—obesity	9.1e-06	0.000148	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—IRS2—obesity	8.85e-06	0.000144	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—AGT—obesity	8.84e-06	0.000143	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—LEP—obesity	8.66e-06	0.000141	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—APOE—obesity	8.66e-06	0.000141	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—IRS2—obesity	8.66e-06	0.00014	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—AGT—obesity	8.64e-06	0.00014	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CAV1—obesity	8.58e-06	0.000139	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—APOA1—obesity	8.56e-06	0.000139	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—LEP—obesity	8.47e-06	0.000137	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—APOE—obesity	8.47e-06	0.000137	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CAV1—obesity	8.39e-06	0.000136	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—APOA1—obesity	8.37e-06	0.000136	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ESR1—obesity	8.27e-06	0.000134	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PRKCB—obesity	8.17e-06	0.000133	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—F2—obesity	8.17e-06	0.000133	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ESR1—obesity	8.09e-06	0.000131	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—BAD—obesity	8.07e-06	0.000131	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PRKCB—obesity	7.99e-06	0.00013	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—F2—obesity	7.99e-06	0.00013	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—BAD—obesity	7.89e-06	0.000128	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PIK3CG—obesity	7.81e-06	0.000127	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—IRS1—obesity	7.72e-06	0.000125	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PIK3CG—obesity	7.64e-06	0.000124	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—IRS1—obesity	7.56e-06	0.000123	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—POMC—obesity	7.44e-06	0.000121	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—INS—obesity	7.4e-06	0.00012	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CCL2—obesity	7.28e-06	0.000118	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—POMC—obesity	7.28e-06	0.000118	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—INS—obesity	7.24e-06	0.000117	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—IGF1—obesity	7.16e-06	0.000116	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—AKT2—obesity	7.15e-06	0.000116	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CCL2—obesity	7.12e-06	0.000116	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—IGF1—obesity	7e-06	0.000114	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—AKT2—obesity	6.99e-06	0.000113	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PIK3CD—obesity	6.87e-06	0.000111	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—PIK3CA—obesity	6.8e-06	0.00011	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—SERPINE1—obesity	6.79e-06	0.00011	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PIK3CD—obesity	6.72e-06	0.000109	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—PIK3CA—obesity	6.66e-06	0.000108	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—SERPINE1—obesity	6.65e-06	0.000108	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—TYK2—obesity	6.61e-06	0.000107	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—RHOA—obesity	6.55e-06	0.000106	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PIK3R1—obesity	6.49e-06	0.000105	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NOS3—obesity	6.49e-06	0.000105	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—TYK2—obesity	6.47e-06	0.000105	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—RHOA—obesity	6.41e-06	0.000104	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PIK3R1—obesity	6.35e-06	0.000103	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NOS3—obesity	6.35e-06	0.000103	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—PIK3CA—obesity	6.18e-06	0.0001	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PIK3CA—obesity	6.04e-06	9.81e-05	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—MTOR—obesity	5.99e-06	9.72e-05	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PIK3CB—obesity	5.99e-06	9.72e-05	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—MTOR—obesity	5.86e-06	9.5e-05	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PIK3CB—obesity	5.86e-06	9.5e-05	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—AKT1—obesity	5.56e-06	9.02e-05	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—IL6—obesity	5.47e-06	8.88e-05	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—AKT1—obesity	5.44e-06	8.82e-05	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—IL6—obesity	5.35e-06	8.69e-05	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—MMP9—obesity	5.2e-06	8.45e-05	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—MMP9—obesity	5.09e-06	8.26e-05	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—MAPK8—obesity	5.06e-06	8.21e-05	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—AKT1—obesity	5.05e-06	8.19e-05	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—MAPK8—obesity	4.95e-06	8.03e-05	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—AKT1—obesity	4.94e-06	8.01e-05	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—STAT3—obesity	4.63e-06	7.51e-05	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—STAT3—obesity	4.53e-06	7.35e-05	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—MYC—obesity	4.3e-06	6.98e-05	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—TGFB1—obesity	4.29e-06	6.96e-05	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—MYC—obesity	4.21e-06	6.83e-05	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—TGFB1—obesity	4.2e-06	6.81e-05	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PIK3CA—obesity	3.65e-06	5.92e-05	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PIK3CA—obesity	3.57e-06	5.79e-05	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—IL6—obesity	3.23e-06	5.24e-05	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—IL6—obesity	3.16e-06	5.13e-05	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—AKT1—obesity	2.98e-06	4.84e-05	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—AKT1—obesity	2.92e-06	4.73e-05	CbGpPWpGaD
